- Home
- PSNL vs PETS Comparison
PSNL vs PETS Comparison
Compare PSNL & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNL
- PETS
- Stock Information
- Founded
- PSNL 2011
- PETS 1996
- Country
- PSNL United States
- PETS United States
- Employees
- PSNL N/A
- PETS N/A
- Industry
- PSNL Medical Specialities
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- PSNL Health Care
- PETS Consumer Staples
- Exchange
- PSNL Nasdaq
- PETS Nasdaq
- Market Cap
- PSNL 321.1M
- PETS 82.0M
- IPO Year
- PSNL 2019
- PETS N/A
- Fundamental
- Price
- PSNL $5.19
- PETS $4.07
- Analyst Decision
- PSNL Strong Buy
- PETS Sell
- Analyst Count
- PSNL 4
- PETS 2
- Target Price
- PSNL $6.81
- PETS $3.50
- AVG Volume (30 Days)
- PSNL 439.4K
- PETS 182.6K
- Earning Date
- PSNL 11-06-2024
- PETS 11-06-2024
- Dividend Yield
- PSNL N/A
- PETS 29.41%
- EPS Growth
- PSNL N/A
- PETS N/A
- EPS
- PSNL N/A
- PETS N/A
- Revenue
- PSNL $80,027,000.00
- PETS $270,772,000.00
- Revenue This Year
- PSNL $10.85
- PETS N/A
- Revenue Next Year
- PSNL $8.77
- PETS $3.27
- P/E Ratio
- PSNL N/A
- PETS N/A
- Revenue Growth
- PSNL 19.20
- PETS 2.26
- 52 Week Low
- PSNL $0.89
- PETS $2.90
- 52 Week High
- PSNL $7.20
- PETS $8.27
- Technical
- Relative Strength Index (RSI)
- PSNL 56.29
- PETS 56.76
- Support Level
- PSNL $4.54
- PETS $3.78
- Resistance Level
- PSNL $5.35
- PETS $4.17
- Average True Range (ATR)
- PSNL 0.30
- PETS 0.18
- MACD
- PSNL 0.05
- PETS -0.01
- Stochastic Oscillator
- PSNL 84.71
- PETS 62.22
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.